WCN24-409 EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NEPHROTIC SYNDROME: A MULTI-INSTITUTIONAL ANALYSIS

WCN24-409 EFFICACY OF DIRECT ORAL ANTICOAGULANTS IN PATIENTS WITH NEPHROTIC SYNDROME: A MULTI-INSTITUTIONAL ANALYSIS

Saved in:

Bibliographic Details
Main Authors:	Brittany Miles, Aun Munis, Ankit Mehta
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924011549
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prophylactic and Therapeutic Anticoagulation in Nephrotic Syndrome Using Direct Acting Oral Anticoagulants
by: Donal J. Sexton, et al.
Published: (2025-04-01)

Nephrotic Syndrome Thromboprophylaxis With Direct Oral Anticoagulants or Vitamin K Antagonists
by: Edouard Cubilier, et al.
Published: (2025-05-01)

WCN25-1332 Evaluating the Role of Direct Oral Anticoagulants as a Safer and Effective Option for Thromboprophylaxis in Nephrotic Syndrome: A Prospective Observational Study
by: Priti Meena, et al.
Published: (2025-02-01)

Venous Thromboembolism Prevention in Nephrotic Syndrome: The Role of Aspirin, Vitamin K Antagonists, and Direct Oral Anticoagulants
by: Zohreh Gholizadeh Ghozloujeh, et al.
Published: (2025-05-01)

WCN24-164 Genetic Screening in Children with Challenging Nephrotic Syndrome
by: Mohamad Bassam Said
Published: (2024-04-01)

DIRECT ORAL ANTICOAGULANTS
by: I. Tzoran, et al.
Published: (2016-06-01)

WCN24-2688 USE OF RITUXIMAB IN STEROID SENSITIVE NEPHROTIC SYNDROME PATIENTS
by: Maia Antonella Loreti, et al.
Published: (2024-04-01)

WCN24-1509 THE ROLE OF NEPHROBIOPSY IN THE VERIFICATION OF STEROIDRESISTANT NEPHROTIC SYNDROME IN CHILDREN
by: Natalya S. Zhuravleva, et al.
Published: (2024-04-01)

Anticoagulation for the Prevention of Thrombotic Events in Nephrotic Syndrome
by: David Massicotte Azarniouch, et al.
Published: (2024-10-01)

WCN24-1673 UNCOMMON CAUSE OF STEROID-RESISTANT NEPHROTIC SYNDROME, CASE REPORT
by: Sofia Victoria Sanchez Cestona, et al.
Published: (2024-04-01)

134 Evaluation of Antiseizure Medication Impact on Efficacy of Direct Oral Anticoagulants
by: Corinne M. Bertolaccini, et al.
Published: (2025-05-01)

WCN24-1037 Minimal change glomerulonephritis steroid-dependent nephrotic syndrome treated with Rituximab
by: FABRIZIO CRISTIANO
Published: (2024-04-01)

WCN24-1378 FROM HODGKIN'S LYMPHOMA TO NEPHROTIC SYNDROME: A DIAGNOSTIC PUZZLE UNVEILED
by: Marina Leiva, et al.
Published: (2024-04-01)

Direct oral anticoagulants for electrical cardioversion
by: A. N. Volovchenko, et al.
Published: (2021-07-01)

Direct Oral Anticoagulants in Cancer Patients
by: Nicolas Bonadies, et al.
Published: (2024-10-01)

Modern possibilities and prospects in evaluating the anticoagulant effect of direct oral anticoagulants
by: A. I. Mironova, et al.
Published: (2022-06-01)

WCN24-1772 HISTOPATHOLOGICAL CHARACTERISTICS IN CHILDREN WITH MONOGENIC AND NON-GENETIC STEROID-RESISTANT NEPHROTIC SYNDROME
by: Larisa Prikhodina, et al.
Published: (2024-04-01)

Direct-acting oral anticoagulants in antiphospholipid syndrome
by: T. M. Reshetnyak, et al.
Published: (2021-01-01)

Exploring the implications of direct oral anticoagulants in trauma
by: Vanessa P Ho, et al.
Published: (2024-07-01)

Use of direct oral anticoagulants in kidney diseases
by: I.A. Paliienko, et al.
Published: (2025-03-01)

Direct oral anticoagulant: Looking beyond convenience
by: Samuel Ji Quan Koh, et al.
Published: (2024-02-01)

WCN24-582 CLINICAL PROFILE AND HISTOPATHOLOGICAL ANALYSIS OF PATIENTS WITH NEPHROTIC SYNDROME IN WONGSONEGORO HOSPITAL, SEMARANG, INDONESIA
by: ITAMURBANI HANDAJANINGRUM, et al.
Published: (2024-04-01)

WCN24-1921 NEPHROTIC SYNDROME SECONDARY AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS DUE TO PODOCYTE KANK-2 MUTATION
by: Sandra Liliana Borda Galindo, et al.
Published: (2024-04-01)

WCN24-2062 CLINICOPATHOLOGICAL CHARACTERISTICS AND LONG-TERM PROGNOSIS OF IgA NEPHROPATHY PATIENTS WITH NEPHROTIC SYNDROME
by: xiaoling zhou, et al.
Published: (2024-04-01)

WCN24-1789 The use of rituximab in childhood steroid-resistant nephrotic syndrome: an international, multi-centre study
by: Eugene Yu Hin Chan, et al.
Published: (2024-04-01)

WCN24-1802 Outcomes in patients with anticoagulant related nephropathy: from bad to worse
by: sergey brodsky, et al.
Published: (2024-04-01)

WCN24-581 IMMUNOSUPPRESSIVE THERAPY FOR NEPHROTIC SYNDROME BASED ON CLINICAL SPECTRUM, LABORATORY, AND HISTOPATHOLOGICAL ANALYSIS FROM KIDNEY BIOPSY: A CASE SERIES OF NEPHROTIC SYNDROME REMISSION
by: ITAMURBANI HANDAJANINGRUM, et al.
Published: (2024-04-01)

PO37 | Single centre experience on anticoagulation in carriers of non-mild inherited thrombophilia: direct oral anticoagulants (DOAC) efficacy and safety
Published: (2025-08-01)

COMPARATIVE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS
by: V. A. Sulimov, et al.
Published: (2015-09-01)

Efficacy and safety of direct oral anticoagulants approved for cardiovascular indications: Systematic review and meta-analysis.
by: Raghavendra Charan P Makam, et al.
Published: (2018-01-01)

164 Safety and Efficacy of the Use of Direct Oral Anticoagulants in Patients with a History of Bariatric Surgery
by: Nicholas Shabanowitz, et al.
Published: (2025-05-01)

Impact on Adherence and Clinical Outcomes of an Anticoagulation Stewardship Program in Users of Direct Oral Anticoagulants
by: Mayra A. Arenas-Beltrán, et al.
Published: (2025-04-01)

WCN24-359 Uncommon Alliance: Portal Hypertension in Diabetic Nephropathy-Related Nephrotic Syndrome with a Healthy Liver
by: Erick Ivan Marrero Santiago, et al.
Published: (2024-04-01)

WCN24-2336 BARIATRIC SURGERY AS AN OPTIONAL SECOND LINE TREATMENT FOR PERSISTENT PROTEINURIA IN OBESE NEPHROTIC SYNDROME PATIENT
by: Leen Khater, et al.
Published: (2024-04-01)

CONCERNING THE SAFETY OF THE DIRECT ORAL ANTICOAGULANTS IN ROUTINE CARE
by: Board Resolution Expert
Published: (2017-07-01)

On improving the safety of new direct acting oral anticoagulants
by: N. Yu. Velts, et al.
Published: (2018-02-01)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs
by: B. A. Tatarsky, et al.
Published: (2021-08-01)

Direct Oral Anticoagulants in Patients With ESRD and Kidney Transplantation
by: Nicholas W. Lange, et al.
Published: (2025-01-01)

Safety and Efficacy of Oral Direct Factor Xa Inhibitors in Patients With Nephrotic Syndrome: Results From a National Retrospective Study
by: Caroline Arches, et al.
Published: (2025-04-01)

WCN24-866 THE TYPE OF HEPARIN USED FOR ANTICOAGULATION IN PATIENTS ON HEMODIALYSIS AFFECTS CARNITINE METABOLISM
by: Kie Sekiguchi, et al.
Published: (2024-04-01)